The ATP‐Regulated Potassium Channel in Ischemia‐Reperfusion Injury

Annals of the New York Academy of Sciences

Volumn 723, Issue 1, 1994, Pages 71-81

  GROSS, G J ^a   YAO, Z ^a   PIEPER, G M ^a   AUCHAMPACH, J A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; APRIKALIM; CROMAKALIM; GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TOLBUTAMIDE;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; HEART CONTRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEMODYNAMICS; MEMBRANE DEPOLARIZATION; NONHUMAN; PATHOPHYSIOLOGY; REPERFUSION INJURY; STUNNED HEART MUSCLE;

EID: 0028306191     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1994.tb36718.x     Document Type: Article

References (35)

1. + channels in cardiac muscle
2. Properties and function of ATP‐sensitive K‐channels
3. Adenosine triphosphate‐sensitive potassium channels in the cardiovascular system
4. + channel openers
5. The sulfonylurea receptor may be an ATP‐sensitive potassium channel
6. Specific block of the anti‐ischemic actions of cromakalim by sodium 5‐hydroxydecanoate
7. + channels plays a crucial role in the control of insulin secretion
8. Hypoxic dilation of coronary arteries is mediated by ATP‐sensitive potassium channels
9. The protective effects of cromakalim and pinacidil on Reperfusion function and infarct size in isolated perfused hearts and anesthetized dogs
10. Pharmacological profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs
11. + channels protect the myocardium against ischemia/reperfusion damage
12. Myocardial protection with preconditioning
13. Effects of AQ‐AH 208, a new specific bradycardic agent on myocardial ischemia‐Reperfusion injury in anesthetized dogs
14. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
15. The stunned myocardium: prolonged postischemic ventricular dysfunction
16. Oxygen‐derived free radicals and myocardial reperfusion injury: an overview
17. Cardioprotective effects of nicorandil
18. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP‐dependent potassium channels
19. Pharmacological evidence for a role of ATP‐dependent potassium channels in myocardial stunning
20. Activation of cardiac KATP channels; an endogenous protective mechanism during repetitive ischemia
21. Animal models of protecting ischemic myocardium (AMP1M): results of the NHLBI cooperative study
22. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
23. Comparative effects of nitroprusside and pinacidil on myocardial blood flow and infarct size in awake dogs with acute myocardial infarction
24. Effects of pinacidil on myocardial blood flow and infarct size after acute left anterior descending coronary artery occlusion and reperfusion in awake dogs with and without a coexisting left circumflex coronary artery stenosis
25. + channel opener aprikalim (RP 52891) reduces experimental inferct size in dogs in the absence of hemodynamic changes
26. 1 adenosine receptors in rabbit heart
27. 1 receptors by G proteins in rat ventricular myocytes
28. Blockade of ATP‐sensitive potassium channels prevents myocardial preconditioning in dogs
29. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode
30. Elevation of cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart
31. Intracellular free calcium concentration measured with 19F NMR spectroscopy in intact ferret hearts
32. Effect of verapamil on postischemic “stunned” myocardium: importance of timing of treatment
33. Effect of intracoronary diltiazem on infarct size and regional function in the ischemic reperfused canine myocardium
34. Ryanodine prevents the changes in myocardial function and morphology induced by reperfusion after brief periods of ischemia
35. The UDGP controversy